United Arab Emirates
Industry
BMI View: Attempts in the Gulf region to take a more preventative stance against public health issues is commendable, but changing attitudes and weaning the population of their tobacco...
2012-02-01Industry
BMI View: The recent increase in immigration to the UAE is good for total market size but increasingly it is becoming divided between indigenous nationals/expatriate professionals and...
2012-01-05Industry
BMI View: As the Gulf Cooperation Council (GCC) is pushing the financial burden of healthcare on to individuals, through the mandating of compulsory health insurance, regulations will...
2011-11-21Industry
BMI View: While emerging pharmaceutical markets are a fantastic growth story, the use of higher prices for drugs in emerging markets to offset the austerity of Europe and US healthcare...
2011-11-18Industry
BMI View: While the biotechnology parks of Dubai and Saudi Arabia have attracted some big names in the global industry, we are concerned that they may have become glorified tax havens...
2011-11-09Industry
BMI View: The rise of lifestyle diseases associated with obesity and the relatively high per capita spending of the Gulf Cooperation Council (GCC) countries is going to attract medical...
2011-10-26Industry
BMI View: A free trade agreement (FTA) between India and the Gulf Cooperation Council (GCC) will help Indian drugmakers to take a greater market share of the generic drug segment, primarily...
2011-10-13Industry
BMI Core View: Corporate social responsibility (CSR) is an under-appreciated business activity in the pharmaceutical industry. Like all commercial entities, drugmakers are fully entitled...
2011-09-26




